Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.550NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.550NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.261NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.261NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.3.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.3.5NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.1.24NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.24NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.320NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.320NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.33NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.33NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.635NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.635NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.21NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.21NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
C.14NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.14NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-17315.1Japan
B.1.258.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.258.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.215NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.215NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.36.20NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.36.20NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.177.82NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.82NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.462NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.462NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.218NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.218NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.462NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.462NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
A.29NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
A.29NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.147NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.147NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
P.1.6 (Gamma)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
P.1.6 (Gamma)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
P.1.5 (Gamma)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
P.1.5 (Gamma)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
P.1.4 (Gamma)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
P.1.4 (Gamma)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.420NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.420NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBB.2.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.2.12NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.39.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.39.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EK.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EK.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used